Dr. Pearl E. Grimes, MD

Dr. Grimes practices at Quest Diagnostics in West Hills, California.

Dr. Grimes' NPI, 1790702751, was assigned on July 16, 2006. Dr. Grimes graduated from Washington University School of Medicine in 1979. Dr. Grimes holds California license G51930.

Dr. Grimes' primary practice is Quest Diagnostics, at 8403 N Fallbrook Ave, West Hills, CA 91304 in Los Angeles County. The practice phone is (800) 877-2515.

Dr. Grimes' primary practice is Quest Diagnostics in West Hills, California. Dmand AI also links Dr. Grimes to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grimes practices. Vendor and product names are available with a free account.

Dermatology is Dr. Grimes' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Grimes is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Grimes' licenses on file in 2 states: California and Maryland.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, scalp rash, shingles, skin cyst and skin discoloration among the conditions Dr. Grimes treats.

CMS data shows 1,066 Medicare services from Dr. Grimes across 11 procedure codes in 2024, for 251 Medicare patients. Medicare paid $78,581 for them. Every service was in an office.

CMS counts 251 Medicare patients who saw Dr. Grimes in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grimes' median patient age at 55, with 70% women.

In 2024, Dr. Grimes wrote 568 Medicare Part D claims for 189 patients. 93% of them were for generic drugs. CMS names the drug for 503 of them, across 18 drugs with 11 or more claims each, at $65,412 in total drug cost. In 2023, CMS named 375 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Grimes for performance year 2024, reported individually. CMS lists Dr. Grimes as offering telehealth. CMS counts 84 procedures of removal of skin lesions by Dr. Grimes, more than 74% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Grimes, published from 2015 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Hyperpigmentation, Administration, Topical and Cysteamine. Dr. Grimes has published most often in J Drugs Dermatol. Dr. Grimes' most frequent co-authors are Nada M. Elbuluk, MD, John E. Harris, MD and Mark Gabriel Lebwohl.

Dmand AI links Dr. Grimes to 3 clinical trials. Conditions studied include Acneiform Eruptions and Acne Vulgaris.

CMS Open Payments shows 196 general payments to Dr. Grimes from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Incyte Corporation paid the most, $159,530. It also lists 2 research payments totaling $147,058 from 2018 to 2023.

Dmand AI lists 6 awards for Dr. Grimes, most recently America's Top Doctors in 2014.

Dr. Grimes graduated from Washington University School of Medicine in 1979. Dr. Grimes is a member of AAD and ASDS.

Dr. Grimes is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.